Is CSTL stock safe? | Glauxie AI

Q: Is CSTL stock safe?

Castle Biosciences, Inc. (CSTL) operates in the Medical - Diagnostics & Research industry (Healthcare sector). The company is led by CEO Derek J. Maetzold. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a... Employees: 883.

Q: What are the risks of investing in CSTL?

Identify key risks of investing in CSTL — debt, competition, volatility, and sector headwinds.

Q: Is CSTL a good long-term investment?

Evaluate CSTL as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does CSTL have?

Review CSTL total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is CSTL stock safe?

🦉

Castle Biosciences, Inc. (CSTL)

Company Overview

Sector / IndustryHealthcare / Medical - Diagnostics & Research

CEODerek J. Maetzold

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed...

Key Executives

Name	Title
Camilla Zuckero	Vice President of Investor Relations & Corporate Affairs
Derek J. Maetzold	Founder, Chief Executive Officer, President & Director
Frank Stokes	Chief Financial Officer & Treasurer
Hillary Caruso	Chief of Staff
Jay Braxton	Vice President of Marketing & Brand Manager of Uveal Melanoma (UM)
Keli Greenberg	Vice President of Human Resources

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CSTL Profile Financials

What are the risks of investing in CSTL? Is CSTL a good long-term investment? How much debt does CSTL have?